Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -56.12% is 21% above its 5-year average of -71.00%, near the high end of its 5-year range (-153.13%–-25.36%).
21.60% below its 12-month average of -46.15%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -25.36%.
EBITDA MARGIN
-56.12%
EBITDA MARGIN AVG TTM
-46.15%
EBITDA MARGIN AVG 3Y
-63.34%
EBITDA MARGIN AVG 5Y
-71.00%
EBITDA MARGIN AVG 10Y
-475.52%
EBITDA MARGIN AVG 15Y
-519.49%
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-21.60%
CURRENT VS 3Y AVG
+11.40%
CURRENT VS 5Y AVG
+20.96%
CURRENT VS 10Y AVG
+88.20%
CURRENT VS 15Y AVG
+89.20%
CURRENT VS 20Y AVG
N/A
Avita Medical Inc.
Market Cap
$319.45M
EBITDA Margin
-56.12%
TTM Avg
-46.15%
3Y Avg
-63.34%
5Y Avg
-71.00%
Market Cap
$321.44M
EBITDA Margin
11.45%
TTM Avg
4.69%
3Y Avg
-3.39%
5Y Avg
-11.89%
Market Cap
$323.89M
EBITDA Margin
-59.31%
TTM Avg
-58.08%
3Y Avg
-69.87%
5Y Avg
-66.91%
Market Cap
$324.72M
EBITDA Margin
-184.07%
TTM Avg
-174.53%
3Y Avg
-153.81%
5Y Avg
-153.81%
Market Cap
$312.35M
EBITDA Margin
-285.23%
TTM Avg
-308.13%
3Y Avg
-415.00%
5Y Avg
-335.56%
Market Cap
$303.90M
EBITDA Margin
-144.24%
TTM Avg
-144.24%
3Y Avg
-144.24%
5Y Avg
-144.24%
Market Cap
$302.13M
EBITDA Margin
-24933.33%
TTM Avg
-24426.94%
3Y Avg
-19832.71%
5Y Avg
-13250.84%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Avita Medical Inc. (RCEL) | $319.45M | -56.12% | -46.15% | -63.34% | -71.00% |
| Agenus Inc. (AGEN)vs › | $318.77M | -9.24% | -56.39% | -95.53% | -82.66% |
| Sanara MedTech Inc. (SMTI)vs › | $321.44M | 11.45% | 4.69% | -3.39% | -11.89% |
| Cabaletta Bio, Inc. (CABA)vs › | $322.85M | N/A | N/A | N/A | N/A |
| ClearPoint Neuro, Inc. (CLPT)vs › | $323.89M | -59.31% | -58.08% | -69.87% | -66.91% |
| CapsoVision, Inc. (CV)vs › | $324.72M | -184.07% | -174.53% | -153.81% | -153.81% |
| C4 Therapeutics, Inc. (CCCC)vs › | $312.35M | -285.23% | -308.13% | -415.00% | -335.56% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $303.90M | -144.24% | -144.24% | -144.24% | -144.24% |
| Benitec Biopharma Inc. (BNTC)vs › | $302.13M | -24933.33% | -24426.94% | -19832.71% | -13250.84% |
| Larimar Therapeutics, Inc. (LRMR)vs › | $291.39M | N/A | N/A | N/A | N/A |
Gross Margin
81.6%
EBITDA Margin
-56.1%
Operating Margin
-59.4%
Net Margin
-57.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -25.36% |
| 2026-03-31 | -42.47% |
| 2025-12-31 | -55.11% |
| 2025-09-30 | -50.28% |
| 2025-06-30 | -57.53% |
| 2025-03-31 | -61.07% |
| 2024-12-31 | -51.87% |
| 2024-09-30 | -69.05% |
| 2024-06-30 | -101.48% |
| 2024-03-31 | -153.13% |
| 2023-12-31 | -85.14% |
| 2023-09-30 | -67.00% |
| 2023-06-30 | -93.75% |
| 2023-03-31 | -92.66% |
| 2022-12-31 | -61.11% |
| 2022-09-30 | -61.70% |
| 2022-06-30 | -74.69% |
| 2022-03-31 | -123.68% |
| 2021-12-31 | -119.91% |
| 2021-09-30 | -82.26% |
| 2021-06-30 | -43.95% |
| 2021-03-31 | -66.45% |
| 2020-12-31 | -107.17% |
| 2020-09-30 | -197.69% |
| 2020-06-30 | -330.49% |
| 2020-03-31 | -395.02% |
| 2019-12-31 | -322.00% |
| 2019-09-30 | -94.77% |
| 2019-06-30 | -606.52% |
| 2019-03-31 | -608.42% |
| 2018-12-31 | -1136.42% |
| 2018-09-30 | -1136.43% |
| 2018-06-30 | -5295.15% |
| 2018-03-31 | -2850.55% |
| 2017-12-31 | -1820.10% |
| 2017-09-30 | -1820.09% |
| 2017-06-30 | -1782.93% |
| 2017-03-31 | -1787.16% |
| 2016-12-31 | -1464.16% |
| 2016-09-30 | -1464.15% |
| 2016-06-30 | -1832.18% |
| 2016-03-31 | -1834.62% |
| 2015-12-31 | -1021.18% |
| 2015-09-30 | -1021.18% |
| 2015-06-30 | -1001.76% |
| 2015-03-31 | -1001.64% |
| 2014-12-31 | -759.30% |
| 2014-09-30 | -759.30% |
| 2014-06-30 | -263.85% |
| 2014-03-31 | -261.63% |
| 2013-12-31 | -267.92% |
| 2013-09-30 | -267.92% |
| 2013-06-30 | -348.12% |
| 2013-03-31 | -348.12% |
| 2012-12-31 | -290.04% |
| 2012-09-30 | -290.04% |
| 2012-06-30 | -399.01% |
| 2012-03-31 | -410.24% |
